Predicting and reducing bloodstream infections from central lines
Part of Infections clinical trials.
This trial uses machine learning to predict infections that can happen with central lines (special IVs placed in large veins) and aims to reduce how often they occur. It focuses on hospitals with the highest infection rates, so you might be eligible if you receive care at one of these hospitals.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a patient at one of the top 20 Providence St. Joseph Health hospitals with the most central line infections.
- You have a central line (a tube placed in a large vein for medicine or fluids).
- You are 18 years old or older.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a catheter lock solution called DefenCath (taurolidine and heparin) against a standard heparin lock to see if it reduces central line bloodstream infections in people receiving IV nutrition (total parenteral nutrition) for more than 3 months.
This study trains nurses in intensive care units (ICUs) in Bangladesh to use evidence-based practices to prevent complications like ventilator-associated pneumonia, pressure injuries, and bloodstream infections from central lines. It aims to improve patient safety and outcomes during ICU stays.
This study aims to reduce infections that can happen when you have a central line, which is a special tube placed in a large vein to give medicines or fluids. It will test ways to improve care for patients with these lines to prevent infections.
This study tests a new method to prevent infections from central lines (special IVs placed in large veins) in intensive care units. If you have a central line in place for more than 24 hours, this research may help improve your safety by finding better ways to avoid catheter-related bloodstream infections.
This study is looking at infections from central lines (special IVs in large veins) in ICU patients across China. It aims to understand how common these infections are and what factors contribute to them.
This trial tests whether a machine learning model can help doctors decide when to order blood cultures for patients in the emergency department. It aims to reduce unnecessary tests while still catching infections.
Hear when a new Central Line Associated Blood Stream Infections (CLABSI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.